Prevalence of depression and associated factors among people living with HIV/AIDS in public hospitals of Southeast Ethiopia.

Journal: BMC psychiatry

Volume: 22

Issue: 1

Year of Publication: 2022

Affiliated Institutions:  Public Health Department, Goba Referral Hospital, Madda Walabu University, Bale Goba, Ethiopia. fikerbuze@gmail.com. Public Health Department, Goba Referral Hospital, Madda Walabu University, Bale Goba, Ethiopia. Nursing Department, Madda Walabu University, Goba Referral Hospital, Bale Goba, Ethiopia. Biomedical Unit, Madda Walabu University, Goba Referral Hospital, Bale Goba, Ethiopia. Pharmacy Department, Madda Walabu University, Goba Referral Hospital, Bale Goba, Ethiopia. Surgery Department, Madda Walabu University, Goba Referral Hospital, Bale Goba, Ethiopia.

Abstract summary 

Depression is the most frequent mental health condition among human immune deficiency virus or acquired immune deficiency syndrome (HIV/AIDS) patients. It has been related to negative health outcomes. This could lead to hospitalization and an increase in medical expenses. This study aimed to assess the prevalence of depression and associated factors among HIV/AIDS patients in public hospitals Bale Zone, Southeast Ethiopia.A hospital-based cross-sectional study design was randomly employed among 554 study participants. A systematic random sampling technique was used to select the study subjects. A structured Patients Health Questionnaires- 9 was used to measure the depression status of HIV/AIDS patients. Data were collected using a pretested interviewer administered structured questionnaire as well as review of patients medical charts or records. Descriptive statistics were computed. Multivariable logistic regression analyses were conducted identify factors associated with the prevalence of depression. Adjusted odds ratio (AOR), along with a 95% confidence interval (CI), was used to estimate the strength of the association. A p-value of < 0.05 was considered statistically significant.The prevalence of depression among the study participants was found to be 44.9% (95% CI: 40.79%, 49.1%). Perceived HIV related stigma is the single most dominant predictor of depression [(AOR = 8.2, 95% CI: (4.96, 13.68)], low income level [(AOR = 3.1, 95% CI: (1.59, 6.22)] Experiencing any form of a side effect of highly active anti-retroviral therapy (HAART) [(AOR = 1.5, 95% CI: (1.04, 2.56)], having normal BMI [(AOR = 0.49, 95% CI: (0.29, 0.8)] being HIV patients at WHO clinical stage II [(AOR = 0.44, 95% CI: (0.22, 0.9)], were significantly associated with prevalence of depression.The study revealed that the prevalence of depression among people living with HIV in the study settings was high, almost two out of every five HIV patients were depressed. Low income level, side effect to HAART, and having HIV related stigma were more likely to suffer from depression.

Authors & Co-authors:  Desta Fikreab F Tasew Alelign A Tekalegn Yohannes Y Zenbaba Demisu D Sahiledengle Biniyam B Assefa Tesfaye T Negash Wogene W Tahir Anwar A Regasa Tadele T Mamo Ayele A Teferu Zinash Z Solomon Damtew D Gezahegn Habtamu H Bekele Kebebe K Regassa Zegeye Z Atlaw Daniel D

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Pandey A, Galvani AP. The global burden of HIV and prospects for control. The Lancet HIV. 2019;6(12):e809–e811. doi: 10.1016/S2352-3018(19)30230-9.
Authors :  16
Identifiers
Doi : 557
SSN : 1471-244X
Study Population
Male,Female
Mesh Terms
Acquired Immunodeficiency Syndrome
Other Terms
ART;Bale Zone;Depression;Ethiopia;HIV/AIDS
Study Design
Descriptive Study,Cross Sectional Study
Study Approach
Systemic Review
Country of Study
Ethiopia
Publication Country
England